Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections

Table 3 The monthly use of health care pathway elements per health state per patient

Health state	Syringes	GP visits	Psychiatrist visits	Ambulatory care visits	General hospital bed days	Psychiatric hospital bed days
Stable: Adherent PP1M	1 PP1M syringe	0.3	3	0	0	0
Stable: Adherent PP3M	0.33 PP3M syringe	0.3	3	0	0	0
Stable: Non-adherent	0	0.3	3	0	0	0
Relapse: Ambulatory care	0	0	6.2	2.17	0	0
Relapse: Hospitalization month 1	0	0	0	0	2	28
Relapse: Hospitalization month 2-8^a	0	0	0	0	0	30
Death	0	0	0	0	0	0

Abbreviations: PP1M, paliperidone palmitate once-monthly injection; PP3M, paliperidone palmitate three-monthly injection; GP, General Practitioner
^aPatients can stay in the 8th hospitalization state for multiple cycles, see Additional file 1, page 2–3

ISSN: 1472-6963